Get the Stockscreener App
0.8541
4.16%
0.0341
After Hours:
.81
-0.0441
-5.16%
Evogene Ltd stock is traded at $0.8541, with a volume of 29,085.
It is up +4.16% in the last 24 hours and up +7.11% over the past month.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.
See More
Previous Close:
$0.82
Open:
$0.8437
24h Volume:
29,085
Relative Volume:
0.07
Market Cap:
$8.45M
Revenue:
$3.95M
Net Income/Loss:
$-14.59M
P/E Ratio:
-0.7346
EPS:
-1.1626
Net Cash Flow:
$-14.46M
1W Performance:
+6.34%
1M Performance:
+7.11%
6M Performance:
-38.11%
1Y Performance:
-14.16%
1-Day Range:
$0.81
$0.859
1-Week Range:
$0.775
$0.8708
52-Week Range:
$0.72
$2.42
Evogene Ltd Stock (EVGN) Company Profile
Compare EVGN vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVGN
Evogene Ltd
|
0.8541 | 8.11M | 3.95M | -14.59M | -14.46M | -1.1626 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-08-21 | Initiated | ROTH Capital | Buy |
| Jul-29-21 | Initiated | Aegis Capital | Buy |
| Dec-01-20 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-16-13 | Initiated | Oppenheimer | Outperform |
Evogene Ltd Stock (EVGN) Latest News
Evogene receives Nasdaq notification - MSN
Evogene Becomes Talk Of Retail Town As Stock Doubles On GenAI Drug, Agri Discovery Model With Google Cloud - MSN
[Form 3] Evogene Ltd. Initial Statement of Beneficial Ownership - Stock Titan
Evogene Ltd Ordinary Shares Share Price TodayLive NASDAQ: EVGN Stock Price Charts, History - Upstox
Macro Review: Is Evogene Ltd attractive for institutional investorsWeekly Gains Report & Risk Managed Investment Signals - baoquankhu1.vn
Movement Recap: Can Evogene Ltd disrupt its industry2026 Recap & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Portfolio Recap: Is Evogene Ltd a play on infrastructure spending2026 Bull vs Bear & AI Forecast for Swing Trade Picks - baoquankhu1.vn
[EFFECT] Evogene Ltd. SEC Filing - Stock Titan
Evogene Ltd. (EVGN) stock price, news, quote and history - Yahoo Finance UK
Evogene receives Nasdaq delisting warning over share price By Investing.com - Investing.com Canada
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification - Lelezard
Evogene reports receipt of Nasdaq minimum bid price notification - marketscreener.com
Evogene receives Nasdaq delisting warning over share price - Investing.com
Evogene Faces Nasdaq Minimum Bid Price Deficiency, Granted Cure Period to September 2026 - TipRanks
Evogene Gets Nasdaq Minimum Bid Price Notification - marketscreener.com
Nasdaq warns Evogene (NASDAQ: EVGN) over $1.00 minimum bid rule - Stock Titan
Evogene Ltd Stock: Pioneering AI-Driven Plant Genomics for Sustainable Agriculture Markets - AD HOC NEWS
Casterra reports successful castor farming trials in Brazil By Investing.com - Investing.com South Africa
Evogene Ltd. (EVGN) Stock Price, News, Quote & History - Yahoo Finance
Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock - Finviz
Casterra reports successful castor farming trials in Brazil - Investing.com
Evogene files for resale of 5.08M shares via warrant exercise - MSN
Brazil field trials show castor oil can scale as a biofuel feedstock - Stock Titan
EVGN SEC FilingsEvogene 10-K, 10-Q, 8-K Forms - Stock Titan
Chipmakers Recap: Will Evogene Ltd stock hit new highs in YEAREarnings Miss & Smart Allocation Stock Tips - baoquankhu1.vn
Market Recap: Is Evogene Ltd stock a hidden gemCEO Change & Precise Buy Zone Tips - baoquankhu1.vn
Evogene (NASDAQ: EVGN) resale registration for 5.08M ordinary shares - Stock Titan
Armistice selling up to 2.45M Evogene shares (NASDAQ: EVGN) - Stock Titan
Evogene Ltd Stock Faces Pressure Amid Biotech Sector Volatility and Pipeline Delays in 2026 - AD HOC NEWS
Evogene Earnings Call: AI Ambition Meets Cash Reality - TipRanks
If You Invested $1,000 in Evogene (EVGN) - Stock Titan
Evogene appoints Dr. Olga Nissan as vice president of business development to drive AI-driven growth - MSN
EVGN PE Ratio & Valuation, Is EVGN Overvalued - Intellectia AI
Evogene (EVGN) director Leon Recanati details share and option holdings - Stock Titan
Evogene (EVGN) director Nir details multiple stock option grants in Form 3 - Stock Titan
Evogene (EVGN) director details stock option grants and vesting - Stock Titan
Evogene (EVGN) chief development officer reports 40,000-share stock option grant - Stock Titan
Evogene (EVGN) director Sarit Firon details long-dated stock option grants - Stock Titan
Evogene (EVGN) CFO details RSU and stock option holdings - Stock Titan
Evogene (EVGN) CEO Haviv Ofer details multi-year stock option grants - Stock Titan
Evogene Ltd Stock (EVGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):